Seyyedehfatemeh Ghalibafan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seyyedehfatemeh Ghalibafan has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Ali R. Djalilian
Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA
2 shared publications - Hajirah N. Saeed
Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA
2 shared publications - Keyhan Sayadpour Zanjani
Fetal and Pediatric Cardiovascular Research Center, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Mohammadali Ashraf
Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL 60612, USA
2 shared publications Sebastian Borges
Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, FL, USA
2 shared publications- Alfonso L. Sabater
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
1 shared publication
Latest Publications
- 13 October 2026
- Published by Wolters Kluwer Health in Cornea
Severe Dupilumab-Associated Ocular Surface Disease: Multicenter Experience and Management Considerations
Purpose: To evaluate severe dupilumab-associated ocular surface disease (DAOSD) and identify clinical features, risk factors, and outcomes associated with delayed ophthalmologic referral. Methods: A multicenter retrospective case series of 13 patients (26 eyes) with severe DAOSD presenting to tertiary centers between January 2014 and April 2026 was conducted. Clinical findings were analyzed alongside a focused review of current evidence on pathophysiology, diagnosis, and management. Results: Initial ocular symptoms were frequently mild and nonspecific, most commonly redness and pruritus (13/13, 100%), followed by blurred vision with tearing (3/13, 23.1%), eye pain (2/13, 15.4%), and mucoid discharge (2/13, 15.4%), contributing to delayed referral. Symptom onset ranged from 0 to 37 months after dupilumab initiation (mean 11.7 months). At presentation, advanced disease manifestations included limbitis (3/13, 23.1%), conjunctivalization with corneal neovascularization (3/13, 23.1%), limbal stem cell deficiency (2/13, 15.4%), and cicatricial conjunctivitis (1/13, 7.7%). Preexisting atopic ocular disease was present in 6/13 patients (46.2%). Management included lubrication, topical corticosteroids, calcineurin inhibitors, and scleral lenses. Dupilumab was discontinued in 7/13 patients (53.8%). Clinical stabilization was achieved in 12/13 patients (92.3%) over a mean follow-up of 21.4 ± 20.3 months. Conclusions: Severe DAOSD may be underrecognized, as mild early symptoms can delay referral and allow progression to advanced, vision-threatening complications. Preexisting ocular surface disease identifies a high-risk subgroup. Early ophthalmologic evaluation and timely referral are essential to prevent irreversible ocular surface damage and vision loss.
- 13 October 2026
- Published by Wolters Kluwer Health in Cornea
Severe Dupilumab-Associated Ocular Surface Disease: Multicenter Experience and Management Considerations
Purpose: To evaluate severe dupilumab-associated ocular surface disease (DAOSD) and identify clinical features, risk factors, and outcomes associated with delayed ophthalmologic referral. Methods: A multicenter retrospective case series of 13 patients (26 eyes) with severe DAOSD presenting to tertiary centers between January 2014 and April 2026 was conducted. Clinical findings were analyzed alongside a focused review of current evidence on pathophysiology, diagnosis, and management. Results: Initial ocular symptoms were frequently mild and nonspecific, most commonly redness and pruritus (13/13, 100%), followed by blurred vision with tearing (3/13, 23.1%), eye pain (2/13, 15.4%), and mucoid discharge (2/13, 15.4%), contributing to delayed referral. Symptom onset ranged from 0 to 37 months after dupilumab initiation (mean 11.7 months). At presentation, advanced disease manifestations included limbitis (3/13, 23.1%), conjunctivalization with corneal neovascularization (3/13, 23.1%), limbal stem cell deficiency (2/13, 15.4%), and cicatricial conjunctivitis (1/13, 7.7%). Preexisting atopic ocular disease was present in 6/13 patients (46.2%). Management included lubrication, topical corticosteroids, calcineurin inhibitors, and scleral lenses. Dupilumab was discontinued in 7/13 patients (53.8%). Clinical stabilization was achieved in 12/13 patients (92.3%) over a mean follow-up of 21.4 ± 20.3 months. Conclusions: Severe DAOSD may be underrecognized, as mild early symptoms can delay referral and allow progression to advanced, vision-threatening complications. Preexisting ocular surface disease identifies a high-risk subgroup. Early ophthalmologic evaluation and timely referral are essential to prevent irreversible ocular surface damage and vision loss.
- Open Access
Vaccine-Associated Anterior Uveitis
Vaccine-associated anterior uveitis (VAAU) is an uncommon ocular inflammatory phenotype reported after several vaccine platforms. It describes anterior segment inflammation occurring after vaccination when infectious, autoimmune, idiopathic, medication-related, and other possible causes have been reasonably excluded. The current literature indicates that post-vaccination uveitis is rare relative to the scale of immunization, although anterior uveitis is frequently reported among post-vaccination ocular inflammatory events. Evidence remains limited by reliance on case reports, case series, retrospective cohorts, and passive surveillance data, which restricts precise incidence estimation and causal interpretation. Accordingly, the available evidence primarily supports a temporal association rather than a confirmed causal relationship. Proposed mechanisms include innate immune activation, molecular mimicry, adjuvant- or formulation-related immune stimulation, bystander activation, delayed-type hypersensitivity, and host susceptibility related to prior uveitis, autoimmune disease, immune dysregulation, or genetic predisposition. Clinically, VAAU may present with redness, pain, photophobia, blurred vision, anterior chamber cells and flare, keratic precipitates, posterior synechiae, elevated intraocular pressure, vitritis, or cystoid macular edema. Most cases described in the literature are mild to moderate and improve with topical corticosteroids and cycloplegic therapy, whereas recurrent, severe, or treatment-intensive courses have been reported mainly in predisposed individuals. Future work should emphasize active surveillance, standardized phenotype-specific reporting, harmonized case definitions, and mechanistic studies to better define risk, recurrence patterns, and causality. Careful interpretation of suspected cases can support accurate diagnosis, patient counseling, and vaccine-safety monitoring without undermining clinically indicated immunization.
Open AccessVaccine-Associated Anterior Uveitis
Vaccine-associated anterior uveitis (VAAU) is an uncommon ocular inflammatory phenotype reported after several vaccine platforms. It describes anterior segment inflammation occurring after vaccination when infectious, autoimmune, idiopathic, medication-related, and other possible causes have been reasonably excluded. The current literature indicates that post-vaccination uveitis is rare relative to the scale of immunization, although anterior uveitis is frequently reported among post-vaccination ocular inflammatory events. Evidence remains limited by reliance on case reports, case series, retrospective cohorts, and passive surveillance data, which restricts precise incidence estimation and causal interpretation. Accordingly, the available evidence primarily supports a temporal association rather than a confirmed causal relationship. Proposed mechanisms include innate immune activation, molecular mimicry, adjuvant- or formulation-related immune stimulation, bystander activation, delayed-type hypersensitivity, and host susceptibility related to prior uveitis, autoimmune disease, immune dysregulation, or genetic predisposition. Clinically, VAAU may present with redness, pain, photophobia, blurred vision, anterior chamber cells and flare, keratic precipitates, posterior synechiae, elevated intraocular pressure, vitritis, or cystoid macular edema. Most cases described in the literature are mild to moderate and improve with topical corticosteroids and cycloplegic therapy, whereas recurrent, severe, or treatment-intensive courses have been reported mainly in predisposed individuals. Future work should emphasize active surveillance, standardized phenotype-specific reporting, harmonized case definitions, and mechanistic studies to better define risk, recurrence patterns, and causality. Careful interpretation of suspected cases can support accurate diagnosis, patient counseling, and vaccine-safety monitoring without undermining clinically indicated immunization.
- Open Access
- 1 August 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-8
Effect of Supplemental Condition-Specific Video Education on Patient Understanding in Vitreoretinal Surgery
Purpose: In-person patient education is central to surgical counseling and informed consent. However, with verbal discussion alone, there may be limited understanding of complex vitreoretinal procedures. This study evaluated whether supplemental condition-specific Vidscrip video education improves patient-reported understanding among individuals undergoing vitreoretinal surgery. Methods: This comparative study enrolled 40 English-speaking patients undergoing vitreoretinal procedures at an academic ophthalmology center between January 1st and December 31, 2025. Patients were randomized to receive standard preoperative physician counseling alone or counseling supplemented with procedure-specific Vidscrip educational videos. Postoperative understanding was assessed using a structured telephone questionnaire administered between 1 week and 1 month after surgery. Five shared items assessed understanding of the eye condition, treatment options, surgical risks, postoperative care, and visual prognosis using 0– 10 rating scales. Additional Vidscrip-specific items evaluated perceived usefulness, effect on questions or concerns, and comparison with in-person consent and other educational resources. Responses were compared using the Mann–Whitney U-test. Results: Twenty patients were assigned to the Vidscrip group and twenty to standard counseling. Mean patient-reported understanding scores were high in both groups, with no significant differences for eye condition (9.25 vs 9.50, P=0.636), treatment options (8.35 vs 9.10, P=0.920), surgical risks (8.95 vs 9.45, P=0.462), postoperative care (9.30 vs 8.88, P=0.627), visual prognosis (8.55 vs 9.55, P=0.118), or total score (44.4 vs 46.5, P=0.792). Nonetheless, 65.0% of Vidscrip patients reported enhanced understanding after viewing, 65.0% reported fewer questions or concerns, and 90.0% felt the platform would be a helpful adjunct for procedural physicians. Conclusion: Supplemental condition-specific video education did not significantly improve postoperative patient-reported understanding compared with standard counseling alone, although most patients in the video group reported that it enhanced their understanding and considered it a helpful adjunct. Most patients continued to prefer in-person communication for clarification and follow-up discussion.
- 1 August 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-8
Open AccessEffect of Supplemental Condition-Specific Video Education on Patient Understanding in Vitreoretinal Surgery
Purpose: In-person patient education is central to surgical counseling and informed consent. However, with verbal discussion alone, there may be limited understanding of complex vitreoretinal procedures. This study evaluated whether supplemental condition-specific Vidscrip video education improves patient-reported understanding among individuals undergoing vitreoretinal surgery. Methods: This comparative study enrolled 40 English-speaking patients undergoing vitreoretinal procedures at an academic ophthalmology center between January 1st and December 31, 2025. Patients were randomized to receive standard preoperative physician counseling alone or counseling supplemented with procedure-specific Vidscrip educational videos. Postoperative understanding was assessed using a structured telephone questionnaire administered between 1 week and 1 month after surgery. Five shared items assessed understanding of the eye condition, treatment options, surgical risks, postoperative care, and visual prognosis using 0– 10 rating scales. Additional Vidscrip-specific items evaluated perceived usefulness, effect on questions or concerns, and comparison with in-person consent and other educational resources. Responses were compared using the Mann–Whitney U-test. Results: Twenty patients were assigned to the Vidscrip group and twenty to standard counseling. Mean patient-reported understanding scores were high in both groups, with no significant differences for eye condition (9.25 vs 9.50, P=0.636), treatment options (8.35 vs 9.10, P=0.920), surgical risks (8.95 vs 9.45, P=0.462), postoperative care (9.30 vs 8.88, P=0.627), visual prognosis (8.55 vs 9.55, P=0.118), or total score (44.4 vs 46.5, P=0.792). Nonetheless, 65.0% of Vidscrip patients reported enhanced understanding after viewing, 65.0% reported fewer questions or concerns, and 90.0% felt the platform would be a helpful adjunct for procedural physicians. Conclusion: Supplemental condition-specific video education did not significantly improve postoperative patient-reported understanding compared with standard counseling alone, although most patients in the video group reported that it enhanced their understanding and considered it a helpful adjunct. Most patients continued to prefer in-person communication for clarification and follow-up discussion.
- Open Access
- 29 May 2026
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 10 (6) , 1193-1201
Comparative Outcomes of Single-Stage Versus Two-Stage Silicone Oil Removal With Phacoemulsification and Intraocular Lens Implantation
Purpose: To compare visual, refractive, and surgical outcomes between single-stage (concurrent) and 2-stage (sequential) silicone oil removal with phacoemulsification and intraocular lens implantation in patients previously managed for retinal detachment. Methods: This retrospective case series included patients who underwent silicone oil removal with cataract extraction between January 2018 and October 2024 at Bascom Palmer Eye Institute. Outcomes evaluated included best-corrected visual acuity (BCVA), spherical equivalent, and refractive accuracy based on median prediction error and mean absolute error. Results: A total of 272 eyes were analyzed: 26 in the sequential group (mean ± SD age, 48.7 ± 12.9 years; 54% male) and 246 in the concurrent group (mean ± SD age, 52.9 ± 12.2 years; 61% male). BCVA improved in both groups, with final median BCVAs of 0.53 logMAR in the sequential group and 0.71 logMAR in the concurrent group ( P = .064). Spherical equivalent was similar between groups ( P = .843), but the sequential group had better refractive predictability with a lower median prediction error compared with the concurrent group (median –0.26 diopters vs 0.21 diopters; P = .008). The mean absolute error was comparable between groups ( P = .662). Subgroup analysis and multivariate regression revealed no significant predictors of outcomes. Cystoid macular edema occurred in 6 eyes in the sequential group (23%) and 7 eyes in the concurrent group (3%); glaucoma or elevated intraocular pressure occurred in 6 eyes in the sequential group (23%) and 16 eyes in the concurrent group (7%) ( P = .013). Conclusions: Both approaches resulted in improved outcomes, with the sequential method providing superior refractive predictability with less hyperopic error and a trend toward better final visual acuity, suggesting a potential advantage for staged procedures in enhancing surgical precision. However, the sequential method was also associated with higher postoperative complication rates, underscoring the need to balance refractive precision with surgical safety when selecting between staged and combined procedures.
- 29 May 2026
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 10 (6) , 1193-1201
Open AccessComparative Outcomes of Single-Stage Versus Two-Stage Silicone Oil Removal With Phacoemulsification and Intraocular Lens Implantation
Purpose: To compare visual, refractive, and surgical outcomes between single-stage (concurrent) and 2-stage (sequential) silicone oil removal with phacoemulsification and intraocular lens implantation in patients previously managed for retinal detachment. Methods: This retrospective case series included patients who underwent silicone oil removal with cataract extraction between January 2018 and October 2024 at Bascom Palmer Eye Institute. Outcomes evaluated included best-corrected visual acuity (BCVA), spherical equivalent, and refractive accuracy based on median prediction error and mean absolute error. Results: A total of 272 eyes were analyzed: 26 in the sequential group (mean ± SD age, 48.7 ± 12.9 years; 54% male) and 246 in the concurrent group (mean ± SD age, 52.9 ± 12.2 years; 61% male). BCVA improved in both groups, with final median BCVAs of 0.53 logMAR in the sequential group and 0.71 logMAR in the concurrent group ( P = .064). Spherical equivalent was similar between groups ( P = .843), but the sequential group had better refractive predictability with a lower median prediction error compared with the concurrent group (median –0.26 diopters vs 0.21 diopters; P = .008). The mean absolute error was comparable between groups ( P = .662). Subgroup analysis and multivariate regression revealed no significant predictors of outcomes. Cystoid macular edema occurred in 6 eyes in the sequential group (23%) and 7 eyes in the concurrent group (3%); glaucoma or elevated intraocular pressure occurred in 6 eyes in the sequential group (23%) and 16 eyes in the concurrent group (7%) ( P = .013). Conclusions: Both approaches resulted in improved outcomes, with the sequential method providing superior refractive predictability with less hyperopic error and a trend toward better final visual acuity, suggesting a potential advantage for staged procedures in enhancing surgical precision. However, the sequential method was also associated with higher postoperative complication rates, underscoring the need to balance refractive precision with surgical safety when selecting between staged and combined procedures.
- 5 March 2026
- Published by Elsevier in The Ocular Surface
- Vol. 40, 216-238
Clinical evidence on allogeneic blood-derived eye drops in ocular surface and corneal diseases
- 5 March 2026
- Published by Elsevier in The Ocular Surface
- Vol. 40, 216-238
Clinical evidence on allogeneic blood-derived eye drops in ocular surface and corneal diseases
- 8 March 2025
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Factors associated with renal scarring in children with vesicoureteral reflux
Introduction: Vesicoureteral reflux (VUR), a prevalent urological disorder in pediatrics, often leads to severe consequences such as renal scarring, hypertension, and end-stage renal diseases. Objectives: This study investigates the prevalence of renal scarring and its potential predisposing factors in children with VUR. Patients and Methods: A prospective cross-sectional study was conducted at a pediatric tertiary referral hospital between 2014 and 2017. Patients diagnosed with VUR underwent TC99m-DMSA scans. The presence of a renal cortical uptake defect on the renal scan was indicative of renal scarring. In cases with a history of pyelonephritis, the persistence of renal cortical defects for ≥12 months following acute pyelonephritis was defined as renal scarring. Results: A total of 93 patients were enrolled, comprising 62 girls (66.7%) and 31 boys (33.3%). The age of the initial visit to the nephrology clinic was 44.29 ± 43.38 months. Tc-99m DMSA scans identified renal scarring in 28 out of 93 (30.1%) patients and 41 out of 186 (22.04%) kidney ureter units (KUUs), encompassing 32 out of 111 (28.8%) refluxing and 9 out of 75 (12%) non-refluxing kidney units. Renal scarring was observed in 6 out of 21 (28.6%) cases with no history of urinary tract infection (UTI), 13 out of 57 (22.8%) cases with a history of pyelonephritis, and 9 out of 15 (60%) cases with a history of cystitis (P=0.02). Patients with renal scarring were diagnosed with VUR at an older age than those without scarring (45.38±37.37 versus 22.21±22.45 months, respectively; P=0.0001). The prevalence of renal scarring was 21.55% among cases seen in the nephrology clinic at or before the age of 5 years, whereas it was 50% among those referred after the age of 5 years (P=0.006). The diagnosis of VUR after age five years was significantly associated with renal scarring (61.5% versus 25%, respectively) (P= 0.003). No significant associations were found between high-grade and mild-to-moderate VUR or between primary and secondary VUR with renal scarring (P>0.05 for both). Conclusion: Renal scarring is prevalent in the VUR population, occurring as frequently in cases with a history of pyelonephritis as in those without. Early detection of VUR can potentially delay the development of renal scarring.
- 8 March 2025
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Factors associated with renal scarring in children with vesicoureteral reflux
Introduction: Vesicoureteral reflux (VUR), a prevalent urological disorder in pediatrics, often leads to severe consequences such as renal scarring, hypertension, and end-stage renal diseases. Objectives: This study investigates the prevalence of renal scarring and its potential predisposing factors in children with VUR. Patients and Methods: A prospective cross-sectional study was conducted at a pediatric tertiary referral hospital between 2014 and 2017. Patients diagnosed with VUR underwent TC99m-DMSA scans. The presence of a renal cortical uptake defect on the renal scan was indicative of renal scarring. In cases with a history of pyelonephritis, the persistence of renal cortical defects for ≥12 months following acute pyelonephritis was defined as renal scarring. Results: A total of 93 patients were enrolled, comprising 62 girls (66.7%) and 31 boys (33.3%). The age of the initial visit to the nephrology clinic was 44.29 ± 43.38 months. Tc-99m DMSA scans identified renal scarring in 28 out of 93 (30.1%) patients and 41 out of 186 (22.04%) kidney ureter units (KUUs), encompassing 32 out of 111 (28.8%) refluxing and 9 out of 75 (12%) non-refluxing kidney units. Renal scarring was observed in 6 out of 21 (28.6%) cases with no history of urinary tract infection (UTI), 13 out of 57 (22.8%) cases with a history of pyelonephritis, and 9 out of 15 (60%) cases with a history of cystitis (P=0.02). Patients with renal scarring were diagnosed with VUR at an older age than those without scarring (45.38±37.37 versus 22.21±22.45 months, respectively; P=0.0001). The prevalence of renal scarring was 21.55% among cases seen in the nephrology clinic at or before the age of 5 years, whereas it was 50% among those referred after the age of 5 years (P=0.006). The diagnosis of VUR after age five years was significantly associated with renal scarring (61.5% versus 25%, respectively) (P= 0.003). No significant associations were found between high-grade and mild-to-moderate VUR or between primary and secondary VUR with renal scarring (P>0.05 for both). Conclusion: Renal scarring is prevalent in the VUR population, occurring as frequently in cases with a history of pyelonephritis as in those without. Early detection of VUR can potentially delay the development of renal scarring.
- Open Access
- 2 March 2021
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 31 (2)
Atrial Septal Defect Device Closure. Is Balloon Sizing Necessary?
Objectives: This study compared the success rate of atrial septal defect device closure in children with and without balloon sizing during the procedure. Methods: This four-year, combined retrospective and prospective study was performed at a single center. All participants underwent transcatheter closure under transthoracic echocardiography and the success rate was analyzed considering the effect of balloon sizing. Results: Eighty-eight patients with a mean age of 6.48 ± 3.32 years were enrolled. Balloon sizing was performedor in 39 (44%) patients. It didn’t change the success rate compared to 49 (56%) patients without balloon sizing. Likewise, age and sex had no effect on thesuccess rate. However; the failure rate was higher in patients with larger defects. Conclusions: The study demonstrated that balloon sizing did not influence the success rate of atrial septal defect device closure, and a precise measurement by echocardiography can be as successful as balloon sizing.
- 2 March 2021
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 31 (2)
Open AccessAtrial Septal Defect Device Closure. Is Balloon Sizing Necessary?
Objectives: This study compared the success rate of atrial septal defect device closure in children with and without balloon sizing during the procedure. Methods: This four-year, combined retrospective and prospective study was performed at a single center. All participants underwent transcatheter closure under transthoracic echocardiography and the success rate was analyzed considering the effect of balloon sizing. Results: Eighty-eight patients with a mean age of 6.48 ± 3.32 years were enrolled. Balloon sizing was performedor in 39 (44%) patients. It didn’t change the success rate compared to 49 (56%) patients without balloon sizing. Likewise, age and sex had no effect on thesuccess rate. However; the failure rate was higher in patients with larger defects. Conclusions: The study demonstrated that balloon sizing did not influence the success rate of atrial septal defect device closure, and a precise measurement by echocardiography can be as successful as balloon sizing.
- Open Access
- 1 January 2021
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2021 (1)
COVID‐19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran
Background . Promptly discovering and counteracting COVID‐19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the virus from those of the underlying diseases can pose a dilemma to physicians. This case series aims to determine the relationship between COVID‐19 and various types of congenial heart disease among children. Patients and Methods . Seven patients from three different medical centers were enrolled. Their detailed demographic information, past medical history, symptoms, type of congenital heart diseases, imaging tests, laboratory tests, medications, and outcomes were analyzed. Results . The patients included 4 infants, 1 child, and 2 adolescents, with a median age of 9 months and a majority of boys. All of them had either obstructive lesions (right or left ventricular outflow tracts) or significant pulmonary hypertension. The more common clinical symptoms were cough, dyspnea, and fever. Two patients did not survive the illness. Conclusion . Prompt treatment of patients with a combination of COVID‐19 and severe obstructive cardiac pathology or pulmonary hypertension is essential due to a risk for serious and/or fatal consequences.
- 1 January 2021
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2021 (1)
Open AccessCOVID‐19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran
Background . Promptly discovering and counteracting COVID‐19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the virus from those of the underlying diseases can pose a dilemma to physicians. This case series aims to determine the relationship between COVID‐19 and various types of congenial heart disease among children. Patients and Methods . Seven patients from three different medical centers were enrolled. Their detailed demographic information, past medical history, symptoms, type of congenital heart diseases, imaging tests, laboratory tests, medications, and outcomes were analyzed. Results . The patients included 4 infants, 1 child, and 2 adolescents, with a median age of 9 months and a majority of boys. All of them had either obstructive lesions (right or left ventricular outflow tracts) or significant pulmonary hypertension. The more common clinical symptoms were cough, dyspnea, and fever. Two patients did not survive the illness. Conclusion . Prompt treatment of patients with a combination of COVID‐19 and severe obstructive cardiac pathology or pulmonary hypertension is essential due to a risk for serious and/or fatal consequences.